HCMT
AGRX

Highland Capital Management (Texas)’s Agile Therapeutics AGRX Stock Holding History

Highland Capital Management (Texas)’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$146K Hold
50
– – 0.01% 307
2019
Q1 		$151K Buy
+50
New +$106K 0.01% 302
2017
Q1 		– Sell
-71
Closed -$813K – 333
2016
Q4 		$813K Buy
71
+59
+492% +$827K 0.04% 185
2016
Q3 		$169K Buy
+12
New +$171K 0.01% 297
2016
Q1 		– Sell
-50
Closed -$980K – 281
2015
Q4 		$980K Sell
50
-18
-26% -$285K 0.03% 182
2015
Q3 		$915K Buy
68
+54
+386% +$959K 0.03% 204
2015
Q2 		$243K Sell
14
-5
-26% -$107K 0.01% 247
2015
Q1 		$355K Buy
+19
New +$333K 0.01% 214

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Highland Capital Management (Texas)'s AGRX Position: Q2 2019 in Review

Highland Capital Management (Texas) held its Agile Therapeutics (AGRX) position steady in Q2 2019 at 50 shares worth $146K. The position accounts for 0.01% of the portfolio, ranked #307.

Highland Capital Management (Texas) first reported a position in AGRX in Q1 2015 and has held it in 8 quarters since. The position peaked at $980K in Q4 2015. 24 funds tracked by Wall St. Rank hold AGRX as of Q2 2019.

  • Highland Capital Management (Texas) held 50 shares of Agile Therapeutics worth $146K as of Q2 2019.
  • Highland Capital Management (Texas) left its Agile Therapeutics share count unchanged in Q2 2019.
  • Agile Therapeutics made up 0.01% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #307 holding.
  • Highland Capital Management (Texas) first reported a position in Agile Therapeutics in Q1 2015 and has held it in 8 quarters since.
  • Highland Capital Management (Texas)'s Agile Therapeutics position peaked at $980K in Q4 2015.
  • 24 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.